Stockreport

Rigel Pharmaceuticals: Strong Growth Trajectory And Commercial Expansion [Seeking Alpha]

Rigel Pharmaceuticals, Inc.  (RIGL) 
Last rigel pharmaceuticals, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.rigel.com
PDF RIGL's product sales grew 72% YoY in 1H FY2025, with diversification reducing reliance on TAVALISSE and GAVRETO showing strong adoption. On FY2025 revenue projections [Read more]